As a clinician, pharmacist, public-health researcher, and academic who has spent several years studying respiratory health across continents, I must deliver a grim and uncomfortable truth: Ghana is quietly suffocating.

Our national health agenda understandably focuses on infectious diseases, maternal and child health, and the rising burden of diabetes, hypertension, and cancer. Yet another crisis is advancing in plain sight. Chronic obstructive pulmonary disease, or COPD, is progressively destroying the lungs, livelihoods, and dignity of thousands of Ghanaians.

COPD is not an inevitable death sentence. It is preventable and treatable. However, the airflow limitation it causes is persistent, and lung damage detected late cannot simply be reversed.

Without early diagnosis, effective treatment, and sustained exposure reduction, patients can experience relentless breathlessness, repeated hospital admissions, disability, and premature death.

The evidence should end any national complacency. Between 1990 and 2021, the estimated number of COPD deaths in Ghana rose by 157%, from 693 to 1,782. The number of people living with the disease increased from approximately 100,000 to more than 300,000. Although the global age-standardized COPD mortality rate fell by about 37% during this period, Ghana’s rate declined by only 7.3%.

These measures are not interchangeable. Ghana’s absolute death toll has risen partly because of population growth and ageing, while the modest decline in its age-standardized mortality rate shows that the country has made far less progress than the world as a whole.

The conclusion is nevertheless unmistakable: Ghana is falling dangerously behind in preventing, detecting, and treating chronic respiratory disease.

Smoking Is Not the Whole Story

Cigarette smoking remains one of the world’s most important causes of COPD. But Ghana cannot import a Western understanding of the disease and assume that tobacco tells the whole story.

Many Ghanaians at risk of chronic respiratory disease have never smoked. Their lungs are being damaged by the environments in which they cook, work, travel, and struggle to survive. Ghana’s COPD epidemic must therefore be understood as both a medical crisis and an environmental-justice crisis.

The toxic kitchen

Across Ghana, many households still depend on wood, charcoal, and other solid fuels for cooking. When these fuels are burned in poorly ventilated spaces, women, children, and others near the cooking area inhale fine particulate matter, carbon monoxide, and other toxic combustion products.

According to estimates from the Global Burden of Disease Study 2021, household air pollution from solid fuels contributed to approximately 40% of COPD deaths in Ghana. This is an attributable-risk estimate rather than a direct count, but it demonstrates the extraordinary respiratory consequences of energy poverty.

A cooking fire should not become a chronic exposure chamber. Yet for many Ghanaian families, preparing a meal still carries an unacceptable respiratory risk.

Choked cities and communities

Ambient air pollution was estimated to contribute to approximately 25% of COPD deaths in Ghana. Vehicular emissions, road dust, open burning, industrial activity, generator fumes, and poorly controlled waste combustion expose urban residents and workers to a dangerous mixture of pollutants.

The people most heavily exposed are often those with the least power to avoid the danger: street vendors, commercial drivers, traffic officers, informal workers, children, and residents of heavily polluted communities.

Clean air cannot remain a privilege available only to people who can afford to live and work away from polluted environments.

The burden on the mind and household

COPD does not affect only the lungs. Breathlessness can reduce mobility, interrupt sleep, end employment, drain household finances, and gradually isolate patients from their families and communities.

A recent community survey conducted by Asthma Ghana in collaboration with the Global Allergy & Airways Patient Platform included 118 respondents living with asthma, COPD, allergies, and related conditions. Participants described emotional exhaustion, financial hardship, disrupted work and education, social withdrawal, and feelings of hopelessness.

They also reported inadequate access to professional mental-health support. Because this was a community survey rather than a nationally representative study, its results should not be generalized to every Ghanaian patient.

Nevertheless, the experiences reported expose an important and frequently neglected dimension of chronic respiratory disease.

Respiratory care must therefore extend beyond prescriptions. Patients need affordable medicines, pulmonary rehabilitation, psychosocial support, protection from discrimination, and assistance in maintaining their livelihoods.

Galamsey: A Respiratory Emergency Beneath the Environmental Crisis

Ghana’s artisanal and small-scale gold-mining sector employs an estimated 500,000 to one million people, many in dusty, poorly ventilated conditions with little protection or health surveillance.

Crushing and processing gold-bearing rock releases respirable crystalline silica, which can cause irreversible lung fibrosis, silicosis, COPD, impaired lung function, and increased susceptibility to tuberculosis. Permanent damage may develop silently while young miners still appear healthy.

Mercury vapour, diesel exhaust, smoke, and mineral dust further threaten respiratory, neurological, renal, and cardiovascular health. Ghanaian studies have documented hazardous exposures and respiratory symptoms among miners.

Unverified claims about specific percentages of miners with dust or heavy metals in their lungs, however, should not be presented as national estimates. The established evidence is already alarming enough.

A Workforce Outside Health Surveillance

Many miners lack enforceable exposure limits, protective equipment, respiratory assessments, and access to occupational healthcare. Persistent cough, chest tightness, breathlessness, reduced exercise tolerance, weight loss, or recurrent respiratory illness requires medical evaluation because silicosis, COPD, asthma, and tuberculosis can produce similar symptoms.

Ghana urgently needs mobile occupational-health teams, exposure monitoring, tuberculosis screening, quality-assured lung-function testing, enforceable dust controls, mercury-risk reduction, and effective referral systems in mining districts.

No young person should have to choose between economic survival and the ability to breathe.

The Healthcare Trap: Misdiagnosis and Delayed Care

COPD often begins quietly. A morning cough, sputum production, reduced stamina, or breathlessness while climbing a hill may be dismissed as a cold, ageing, fatigue, or poor physical fitness.

By the time some patients reach a major hospital, their disease is advanced. They may already have experienced years of declining lung function, repeated treatment for presumed infections, or unmonitored use of short-acting reliever inhalers.

The delay is not simply a matter of individual negligence. Ghana’s health system remains inadequately equipped to detect chronic respiratory disease early.

The diagnostic gap

COPD cannot be confirmed solely from symptoms, a chest X-ray, or a peak-flow reading. International standards require quality-assured spirometry demonstrating persistent airflow obstruction after administration of a bronchodilator (Global Initiative for Chronic Obstructive Lung Disease.

Spirometry capacity in Ghana remains limited, particularly outside larger hospitals. Shortages of functioning equipment and trained personnel capable of performing and interpreting the test contribute to underdiagnosis, misclassification, and delayed care.

Ghana must expand access to spirometry at regional and district levels while establishing standards for training, calibration, infection prevention, quality control, interpretation, and referral.

The treatment gap

Ghana’s broader noncommunicable-disease programmerecognizes chronic respiratory diseases, but the country does not yet have a fully resourced, nationwide COPD pathway guaranteeing early detection, essential inhalers, pulmonary rehabilitation, follow-up, and specialist referral.

The availability and affordability of inhaled medicines remain inconsistent. Patients may have to pay substantial out-of-pocket costs or travel between facilities to obtain prescribed treatment. Insurance coverage on paper does not always translate into a reliable supply at the point of care.

When controller inhalers are unaffordable or unavailable, patients may ration doses, depend excessively on short-acting relievers, or abandon treatment. The resulting deterioration is then treated as a personal failure of adherence rather than a predictable consequence of an inaccessible health system.

The Immediate Opportunity: Mobilizing Community Pharmacists

Ghana cannot build dozens of specialist respiratory centresovernight. It can, however, use a skilled and widely distributed health workforce that many patients already consult: community pharmacists.

People with persistent cough or breathlessness frequently visit a pharmacy before entering a hospital. They may repeatedly purchase cough mixtures, antibiotics, chest rubs, or reliever inhalers without receiving an assessment of the underlying problem. That repeated encounter is an opportunity for intervention.

Community pharmacists should not independently diagnose COPD on the basis of symptoms or peak flow. They can, however, play a transformative role in targeted case-finding, inhaler education, exposure counselling, treatment support, and timely referral.

A national pharmacy-based respiratory pathway should include the following components.

1. End the revolving door of symptomatic treatment

Pharmacists should be trained to recognize respiratory red flags, including persistent cough, progressive breathlessness, recurrent “chest infections,” reduced exercise tolerance, frequent reliever-inhaler use, hemoptysis, and significant exposure to biomass smoke, tobacco, mining dust, industrial fumes, or urban pollution.

A patient repeatedly returning for cough medicine should not simply receive another bottle. That pattern should trigger structured questioning and, when indicated, referral for medical assessment and spirometry.

2. Use simple tools for case-finding, not definitive diagnosis

Validated symptom and exposure questionnaires can help identify people at increased risk. Peak-flow meters or handheld screening devices may support triage where spirometry is unavailable, but they cannot confirm COPD or reliably distinguish it from asthma and other respiratory conditions.

An abnormal result should lead to referral for quality-assured, post-bronchodilator spirometry. Peak flow must therefore be presented as a case-finding aid, not “proof” of COPD. The correct pathway is straightforward:

Community pharmacy contact → symptom and exposure assessment → case-finding measurement where appropriate → formal referral → confirmatory spirometry and medical evaluation

3. Make inhaler education a standard professional service

An inhaler is effective only when the medicine reaches the lungs. Incorrect timing, inadequate inhalation, failure to prepare the device, and poor coordination can substantially reduce drug delivery.

Although a Ghana-specific national estimate showing that 70% of respiratory patients misuse inhalers could not be verified, international studies demonstrate that critical inhaler errors are common.

Ghanaian research has also shown that structured pharmacist-led asthma education, including correction of inhaler technique, can improve patients’ quality of life and peak expiratory flow.

Every inhaler dispensed should therefore be accompanied by demonstration, patient return-demonstration, correction of errors, and reassessment at subsequent visits.

4. Establish referral and feedback systems

Screening without follow-up is not care. Pharmacies need standardized referral forms, clearly identified receiving facilities, emergency-escalation criteria, and a mechanism through which the pharmacist can learn whether the patient completed the referral.

Community pharmacists must be integrated into the primary-care system rather than treated as isolated retail providers.

A National Right to Breathe

Ghana’s COPD crisis cannot be solved by the health sector alone. The Ministry of Health and Ghana Health Service must establish a national chronic respiratory-care pathway covering prevention, case-finding, spirometry, essential medicines, pulmonary rehabilitation, mental-health support, and referral.

The Pharmacy Council, Ghana College of Pharmacists, professional associations, and training institutions should develop standardized respiratory-care competencies for community pharmacists.

The National Health Insurance Authority must ensure that essential inhalers and diagnostic services are not merely listed but reliably available and affordable.

Environmental and local-government authorities must enforce air-quality standards, regulate open burning and vehicular emissions, accelerate access to clean household energy, and protect communities located near major pollution sources.

Mining regulators must treat occupational lung disease as seriously as water contamination. Dust suppression, ventilation, respiratory protection, mercury-risk reduction, exposure monitoring, and medical surveillance must become enforceable requirements rather than optional precautions.

Universities and research institutions must generate stronger Ghanaian evidence on COPD prevalence, occupational exposure, inhaler access, treatment outcomes, and the effectiveness of pharmacy-led case-finding.

Most importantly, chronic breathlessness must no longer be normalized.

Every day of delay pushes another mother cooking over a smoky fire, another street worker breathing polluted air, and another young miner inhaling silica-rich dust closer to preventable disability.

Ghana does not lack the knowledge to act. It lacks the political urgency, coordinated investment, and accountability required to translate that knowledge into protection.

The country must clear the air, strengthen diagnosis, make treatment affordable, protect exposed workers, and empower community pharmacists to intervene early.

Breathing is not a luxury. It is not a privilege reserved for people who can afford specialist care or cleaner environments.

It is a fundamental condition of life, dignity, and national development. Ghana must give its people the right to breathe.